MichaelKennethKengMD

Hematologic Oncology

Physician

Dr. Keng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1240 Lee St
Charlottesville, VA 22908
Phone+1 434-924-9333

Fax+1 434-243-6086

Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2011 - 2014
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2007 - 2010
Michigan State University College of Human MedicineClass of 2007

PubMed

Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.
Joseph F Mort, David Brighton, Samantha DiBenedetto, Leah Wells, Stephen M Clark
European Journal of Haematology. 2025-03-01
Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Associ...
Victoria Nachar, Marjorie Adams Curry, Diana Kostoff, Angela Wood, Karen B Farris
JCO Oncology Practice. 2025-01-23
1 citations
MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications.
Valerie Tran, Kiarash Salafian, Kenan Michaels, Caroline Jones, Daniel Reed
Current Hematologic Malignancy Reports. 2024-08-01

Abstracts/Posters

Distance Does Not Matter: Excellent Survival Outcomes for Leukemia Patients in Rural Appalachia
Michael K Keng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
Michael Keng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Oral Regimen for Urine Alkalization in Patients Receiving High Dose Methotrexate during a National Shortage of Intravenous Sodium Bicarbonate
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018